Kylänpää-Bäck M L, Kemppainen E, Puolakkainen P, Hedström J, Haapiainen R, Korvuo A, Stenman U H
Department of Surgery, Helsinki University Central Hospital, P.O. POX 340, 00290 Helsinki, Finland.
Hepatogastroenterology. 2002 Jul-Aug;49(46):1130-4.
BACKGROUND/AIMS: The accuracy of a new rapid urinary trypsinogen-2 test strip (actim Pancreatitis) was compared with that of serum lipase for detection of acute pancreatitis in patients with acute abdominal pain.
A prospective study was conducted which consisted of 237 consecutive patients with acute abdominal pain admitted to the emergency unit at Helsinki University Central Hospital. The patients were tested on admission with the actim Pancreatitis test strip. Serum amylase, serum lipase, and urine trypsinogen-2 concentrations were also determined quantitatively.
The actim Pancreatitis test strip result was positive in 27 out of 29 patients with acute pancreatitis (sensitivity 93%) and in 16 of 208 patients with non-pancreatic abdominal pain (specificity 92%). This was superior to that of serum lipase (sensitivity 79% and specificity 88%). With a cut-off > 3x the upper reference limit, the sensitivity of serum lipase was only 55% while the specificity was 99%. The high sensitivity for the actim Pancreatitis test strip resulted in a very high negative predictive value of 99%. All six patients with severe acute pancreatitis were detected by the dipstick. With a higher cut-off value (> 3x upper reference limit) for lipase, two patients with severe acute pancreatitis remained undetected. Combining the actim Pancreatitis dipstick with serum lipase a positive predictive value of 94% was obtained.
Acute pancreatitis can be excluded with a higher probability with the actim Pancreatitis strip than with serum lipase determination, and therefore appears to be more suitable for screening of acute pancreatitis. With its high specificity with a cut-off > 3x the upper reference limit, serum lipase is suitable as a confirmatory test for pancreatitis when a positive dipstick result is obtained.
背景/目的:将一种新型快速尿胰蛋白酶原-2检测试纸(actim胰腺炎检测试纸)与血清脂肪酶检测急性腹痛患者急性胰腺炎的准确性进行比较。
进行了一项前瞻性研究,纳入了赫尔辛基大学中心医院急诊科连续收治的237例急性腹痛患者。患者入院时用actim胰腺炎检测试纸进行检测。同时还定量测定了血清淀粉酶、血清脂肪酶和尿胰蛋白酶原-2浓度。
29例急性胰腺炎患者中有27例actim胰腺炎检测试纸结果呈阳性(敏感性93%),208例非胰腺性腹痛患者中有16例呈阳性(特异性92%)。这优于血清脂肪酶(敏感性79%,特异性88%)。当临界值>正常参考上限的3倍时,血清脂肪酶的敏感性仅为55%,而特异性为99%。actim胰腺炎检测试纸的高敏感性导致其阴性预测值高达99%。所有6例重症急性胰腺炎患者均被试纸检测出。对于脂肪酶采用更高的临界值(>正常参考上限的3倍)时,有2例重症急性胰腺炎患者未被检测出。将actim胰腺炎检测试纸与血清脂肪酶联合使用,阳性预测值为94%。
与血清脂肪酶测定相比,actim胰腺炎检测试纸更有可能排除急性胰腺炎,因此似乎更适合用于急性胰腺炎的筛查。当临界值>正常参考上限的3倍时,血清脂肪酶具有高特异性,在试纸检测结果为阳性时适合作为胰腺炎的确诊试验。